Search

Search Constraints

You searched for: Author/Creator Chu, Chi-Jen

Search Results

1. A 12-week rescue therapy by PrOD-based regimen for advanced fibrotic genotype-1 CHC patients who failed to pegylated interferon plus ribavirin. Issue 3 (March 2019)

2. Daclatasvir plus sofosbuvir, with or without ribavirin, is highly effective for all kinds of genotype-2 chronic hepatitis-C infection in Taiwan. Issue 9 (September 2019)

3. Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma. (May 2022)

4. Highly effective treatment response and well tolerability by all oral direct acting antivirals for chronic hepatitis C patients post organ transplantation. Issue 1 (January 2020)

5. Persistent liver inflammation in chronic hepatitis C patients with advanced fibrosis after direct-acting antivirals induced sustained virological response. Issue 5 (30th April 2021)

6. Sofosbuvir-based antiviral therapy provided highly treatment efficacy, safety, and good tolerability for Taiwanese chronic hepatitis C patients with decompensated cirrhosis. Issue 2 (11th November 2021)

8. Well tolerability and highly effective treatment response for hepatitis C virus-human immunodeficiency virus–coinfected patients treated by all-oral direct-acting antivirals. Issue 5 (30th April 2021)